Gainers
- Intellia Therapeutics NTLA shares increased by 54.9% to $137.6 during Monday's regular session. The current volume of 15.6 million shares is 1205.08% of Intellia Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $9.3 billion.
- Graybug Vision GRAY shares rose 20.76% to $6.28. As of 12:30 EST, this security is trading at a volume of 11.6 million shares, making up 612.08% of its average full-day volume over the last 100 days. The company's market cap stands at $132.2 million.
- Anavex Life Sciences AVXL shares rose 20.22% to $29.75. As of 12:30 EST, this security is trading at a volume of 8.5 million shares, making up 448.61% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.1 billion.
- Iterum Therapeutics ITRM stock increased by 17.63% to $2.44. The current volume of 37.1 million shares is 348.67% of Iterum Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $436.2 million.
- Beam Therapeutics BEAM stock rose 16.98% to $109.79. Beam Therapeutics's stock is trading at a volume of 2.0 million shares as of 12:30 EST. This is 244.47% of its average full-day volume over the last 100 days. The company's market cap stands at $6.8 billion.
- Reshape Lifesciences RSLS stock increased by 15.66% to $6.94. Reshape Lifesciences's stock is trading at a volume of 18.9 million shares as of 12:30 EST. This is 2409.57% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $24.2 million.
Losers
- Exelixis EXEL shares decreased by 20.18% to $18.7 during Monday's regular session. As of 12:30 EST, Exelixis's stock is trading at a volume of 7.7 million, which is 473.52% of its average full-day volume over the last 100 days. The company's market cap stands at $5.8 billion.
- Atossa Therapeutics ATOS stock fell 14.74% to $7.35. The current volume of 23.5 million shares is 142.1% of Atossa Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $888.0 million.
- Osmotica Pharmaceuticals OSMT shares decreased by 12.44% to $3.31. Trading volume for this security as of 12:30 EST is 2.0 million, which is 178.38% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $207.6 million.
- Applied Therapeutics APLT stock declined by 10.26% to $22.23. Applied Therapeutics's stock is trading at a volume of 79.3K shares as of 12:30 EST. This is 84.11% of its average full-day volume over the last 100 days. The company's market cap stands at $579.7 million.
- Trevena TRVN shares fell 8.93% to $1.78. The current volume of 4.2 million shares is 129.27% of Trevena's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $292.0 million.
- Global Blood Therapeutics GBT shares decreased by 8.32% to $33.41. Trading volume for Global Blood Therapeutics's stock is 1.6 million as of 12:30 EST. This is 168.44% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.0 billion.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in